WKN DE: A2P208 / ISIN: US68622P1093

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

ORIC Pharmaceuticals Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
21:55:43	11,905
21:46:46	11,865
21:32:19	11,875
21:17:05	11,865
21:02:23	11,815
20:47:08	11,830
20:31:32	11,780
20:17:00	11,805
20:01:40	11,765
19:47:03	11,770
19:32:06	11,750
19:17:02	11,745
19:02:22	11,765
18:46:59	11,750
18:32:00	11,695
18:17:36	11,695
18:02:34	11,640
17:31:56	11,670
17:17:20	11,635
17:02:36	11,675
16:33:12	11,585
16:18:05	11,670
15:33:46	11,690
15:18:54	11,775
15:03:28	11,660
14:48:32	11,650
14:33:38	11,650
14:18:48	11,640
13:47:24	11,705
13:32:45	11,705
13:18:26	11,715
13:04:12	11,700
12:49:31	11,700
12:46:57	11,705
12:32:50	11,695

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu ORIC Pharmaceuticals Inc Registered Shs

Weitere Meldungen

23:46		US stocks: Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
23:30		Mamdani Persuades C.E.O.s to Join His Business Advisory Council
23:29		DuckDB: Amazon.com kauft Duck Labs
23:19		Marvell Reports Thursday. Here's Where the Google Contract Would Actually Show Up in the Numbers.
23:18		Stock Market Today, Aug. 26: Meta Gains on $18 Billion Child-Safety Settlement
23:11		Stock Market Today, Aug. 26: Boston Scientific Shares Fall 5% on Cybersecurity Incident and Product Recall
23:10		Accuray (ARAY) Q4 2026 Earnings Call Transcript
23:08		BILL (BILL) Q4 2026 Earnings Call Transcript
23:06		Dolly Parton’s Other Legacy: A Fortune Given Away, Dollar by Dollar
23:05		How Much More Power Do AI Data Centers Need Right Now? Morgan Stanley Says 38 Gigawatts. Here Are 3 Stocks Cashing In on That Opportunity.
23:02		Stock Market Today, Aug. 26: Nike Stock Hits 10-Year Low on Analyst Downgrade Following Retail Footwear Concerns
22:59		Nvidia projects 70% sales growth next year as AI boom shows no sign of slowing
22:47		Stock Market Today, Aug. 26: Snap Sued by Pennsylvania Over Addictive Features and Child Safety
22:45		Here’s How Much You Would Have Made Owning Howmet Aerospace Stock In The Last 5 Years
22:44		Nvidia Q2 Highlights: Double Beat, Huang Says ‘AI Infrastructure Buildout is at Full Steam’
22:43		HP Stock Sinks After Q3 Print — What You Need to Know
22:40		IREN Q4 Preview: Stock Down 48% From Highs, Will Data Center Monetization Shine Through in Earnings?
22:39		Salesforce Stock Soars On Q2 Double Beat, 'Claudeforce' Anthropic Partnership
22:36		US Department of Energy awards $10M for critical minerals R&D
22:36		Synopsys Shares Slip Despite Strong Q3 Results: Details
22:32		SpaceX Is Adding 500,000-Plus Starlink Subscribers Every Month. Here's Why That's Critical for the Stock.
22:30		Here's How Much $1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth Today
22:30		Why Box Stock Ticked Higher on Wednesday
22:30		I'd Rather Own Bloom Energy Than Nvidia Right Now. Here's My Case.
22:23		CrowdStrike Reports Beat-and-Raise Q2: 'Best Quarter' in Company History
22:18		Okta Stock Rallies After Q2 Earnings Beat Estimates
22:17		Apple Is One of the Most Profitable Businesses in the World. Here's Why the Stock Will Be Worth $366 a Share in 1 Year.
22:15		Here's How Much $100 Invested In BlackRock 20 Years Ago Would Be Worth Today
22:15		Lumentum Shares Rise Over 4% After Key Trading Signal
22:15		What Investors Should Know About Freshpet CEO William Cyr's $6.6 Million Stock Sale
22:10		Anthropic’s Claude Study Reveals Surprising Shift in How Humans Work With AI
22:00		OpenAI Loses Data Center Chief During Broader Executive Turnover
22:00		If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today
21:58		GTA 6 Netflix Special Could Come at Perfect Time With Leaks Out: Will Take-Two Stock Rebound?
21:56		Why D-Wave Quantum Stock Was Plummeting Today
21:53		Buyers Are Backing Away, and Homebuilder ETFs Are Next in Line
21:41		Peter Thiel and David Tepper Are Buying Amazon Stock Hand Over Fist: Should You Follow the Smart Money?
21:39		American Eagle Outfitters Stock Climbs Wednesday: What's Driving the Action?
21:30		Obesity Drug Alert: Eli Lilly Study Shows Sustained Zepbound Treatment Reduces Hospital Visits, Medical Costs
21:30		Marvell Technology Could Swing $20.8 Billion After Earnings
21:28		RedBird nears deal for Puck at $250mn valuation in latest digital media bet
21:20		Beam Global Stock Rallies Wednesday: What's Going On?
21:16		Banks Fought Stablecoins For Years, JPMorgan Now Evaluates Its Own: 'We Would Evaluate All Options'
21:12		Cameco Owns the Refinery at the Center of Canada's Uranium Threat
21:09		SpaceX Bulls Aren't Thinking Big Enough, Morgan Stanley Says
21:05		Uber Stock Is Trading Lower Today: What's Going On?
21:00		How Does Congress Feel About Nvidia Stock Ahead of Q2 Earnings? Here’s How Many Have Sold in 2026
21:00		OpenAI says it took a week to detect its AI models had hacked Hugging Face
20:57		Why Urban Outfitters Stock Rallied Today
20:51		Crowdstrike Earnings Prediction Market Preview: What Will George Kurtz Say About AI?

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Windtree Therapeutics Trillium Acquisition Tortoise Energy Infrastructure China Liberal Education Holdings 2020 Mandatory Exchangeable Trust Exch

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	26.08.2026 23:56
Kaufwert:	EUR
	Hinzufügen Speichern

ORIC Pharmaceuticals Aktie

WKN DE: A2P208 / ISIN: US68622P1093

ORIC Pharmaceuticals Times and Sales (STU)

Analysen zu ORIC Pharmaceuticals Inc Registered Shs

Weitere Meldungen